Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ascendis Pharma A/S (ASND) vs Cassava Sciences Inc (FLNA) Price & Performance

Ascendis Pharma A/STrade
Cassava Sciences IncTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Cassava Sciences Inc — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Ascendis Pharma A/S is far larger — about 349.1× Cassava Sciences Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.

ASNDFLNA
Market Cap
$16.67B$47.75M
Sector
HealthHealth
52-Week High
$277.18$4.64
52-Week Low
$189.74$0.87
Enterprise Value
$17.04B-$34.93M

Returns comparison

Trailing returns across standard periods

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Read more on ASND

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA